Because GCTG is a crucial catalytic enzyme in amino acid metabolism and its high expression in LUAD tissue was confirmed in clinical specimens, we speculate that PTL inhibits GCTG and thus affects the amino acid reprogramming of cancer cells. The gene discussed is PNLIP; the disease is cancer.